Researchers at UAB are studying a new HIV vaccine designed to stimulate strong, targeted immune responses. We are looking for HIV-negative adults ages 18–55 who are in overall good health to participate in this Phase 1 study. Visits include safety checks, blood draws, and scheduled vaccinations. Compensation is provided for eligible participation. Call 205-934-7492 or email avrc@uabmc.edu

For more than 30 years, UAB’s Alabama Clinical Research Site has been at the forefront of HIV and infectious disease research, conducting studies through national clinical trials networks. We are currently building a registry of adults who are interested in being contacted about future research opportunities at the Alabama Clinical Research Site. People we are looking for include: Adults 18 and older who live in or near Birmingham People who are living with HIV and receiving care People who do not have HIV but are interested in HIV prevention, vaccines, or other infectious disease research Community members from groups most impacted by HIV in Alabama who want to help shape future prevention and treatment options Joining the registry only means we may contact you to explain future studies; you are never obligated to enroll. If you are eligible and choose to participate in a study, you may receive compensation for your time and travel. For more information or to be added to our registry, call 205-934-7492 or email us at avrc@uabmc.edu

The Alabama Vaccine Research Clinic (AVRC) at UAB is seeking healthy adults ages 18 to 65 to take part in a national HIV prevention study. This Phase 2 clinical trial is testing the safety and potential benefits of three investigational monoclonal antibodies—lab-made proteins that may help the body block HIV. These antibodies are given by IV infusion, not as a shot or vaccine, and participants are never exposed to HIV. Those who qualify will receive two infusions over six months, followed by routine clinic visits for up to one year. Participants will receive compensation for their time and effort. To learn more, call 205-934-7492, email avrc@uabmc.edu.

Do you struggle with anxiety, depression, or feel that your quality of life has suffered due to your HIV diagnosis? Researchers in the Department of Psychology at The University of Alabama at Birmingham are conducting a clinical trial of Acceptance and Commitment Therapy for the treatment of mental health concerns among men who have sex with men and are living with HIV. Volunteers will attend 8 weekly roughly 1 hour sessions of psychotherapy delivered via HIPAA-compliant Zoom by a doctoral student in Medical/Clinical Psychology at University of Alabama at Birmingham. Participants will receive $10 upon completion of initial intake session and an additional $15 upon completion of final therapy session. To participate, you must be an active patient of UAB's 1917 clinic. Complete this online screener to indicate interest: https://uab.co1.qualtrics.com/jfe/form/SV_8H8oWPLXTK532DQ Reach out to uabACThivtrial@gmail.com with any questions.

Study includes up to 12 in-person sessions of weekly counseling for free Remuneration in the form of up to three distributions of $25 for completing three surveys over the course of the study ($75 total) To be included: You must be an adult (18 or older) Identify as LGBTQ+ Our study is a counseling intervention designed to address mental health concerns related to identity-related minority stress. However, there are a few conditions that we do not think would be a good fit. If you are experiencing severe drug addiction, past year history of suicide attempt/self-injury, eating disorder problems, or struggling with psychosis you would not be eligible for this study. Please email Drew Whittington if interested in participating: whitdrew@uab.edu.

Join us at the Alabama Vaccine Research Clinic at UAB! We are seeking participants who were assigned male at birth, are 18 years or older, are not living with HIV, have had receptive anal intercourse (RAI) and regularly douche before intercourse. Participants must not have taken oral or injectable PrEP (pre-exposure prophylaxis) for 8 weeks prior to screening. Our clinical trial will help in the development of an on-demand PrEP in the form of a rectal douche. Your involvement will include simple procedures such as medical and sexual history collection, blood and urine sample testing, a physical exam, and receiving PrEP products in the form of an oral pill and a douche. Compensation will be available for your time and effort. If you are interested, please call 205-934-6777, 205-975-2839 or email avrc@uabmc.edu. You can also fill out our contact form at https://sites.uab.edu/avrc/contact-us/

Are you experiencing pain due to endometriosis? Please consider joining a research study looking at a potential new medication to help women experiencing moderate to severe endometriosis-related pain. Study medication provided at no cost. Participants receive compensation for each visit completed. For more information please call 205-934-1322 or email slangan@uabmc.edu.

Do you identify as an individual living with cancer and part of the LGBTQIA+ community or a care partner of someone in this community? A research lab at the University of Alabama at Birmingham is looking to learn about the day-to-day experiences of LGBTQIA+ cancer survivors and their care partners. We are interested in how individuals manage difficult situations related to their respective roles in their relationships. Individuals living with cancer often encounter stressful situations that can impact their mood and any additional stressors from living as a sexual or gender minority with a lack of resources adds an increased risk of experiencing stressful situations. The goal of this work is to develop resources that better support the well-being of LGBTQIA+ individuals living with cancer and their care partners. This study will take place FULLY online with completion of daily surveys. All participants will be compensated. To learn more about our study contact us at starlab@uab.edu

We are looking for people who identify as trans or cisgender, are 18-65 years of age and would like to take part in a research study examining the impact of gender identity, hormone levels and sex assigned at birth to pain sensitivity and immune cell activity. The commitment to this study will last approximately 3 hours where you will fill out questionnaires, have a single blood draw and take part in pain sensitivity testing. Participants must: Be free from certain health conditions (HIX+, cardiovascular disease, uncontrolled hypertension). Participants can be on HRT (hormone replacement therapy) or not. Participants will receive up to $100. To find out more about this study, call 205-834-3625 or email shinestudyuab@gmail.com.

This study is being done to better understand sexual health in the transgender community. Eligible volunteers will be compensated. If interested, please call (205) 934-8166.